Position in RCUS
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$5,603,040
+$3,563,907 QoQ
Shares Held
259,400
+203.1% QoQ
Ownership
0.206%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2020
18 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RCUS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026D. E. Shaw & Co., Inc. holds $4,371,472,260 across 180 Biotechnology names. RCUS ranks #85 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,625,825 | $919,934,903 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,059,062 | $350,411,843 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
2,545,486 | $189,027,789 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
2,865,318 | $166,503,628 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,603,063 | $154,535,371 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
1,868,708 | $120,774,597 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
1,640,381 | $111,759,157 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
248,960 | $111,170,598 |
All Filings in RCUS
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $5,603,040 | 259,400 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,039,133 | 85,570 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $270,245 | 19,871 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $417,777 | 51,324 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $439,921 | 56,041 | Shares | Defined | 2025-05-15 | |
| 2024-09-30 | $206,430 | 13,501 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $468,550 | 30,765 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $1,275,192 | 67,542 | Shares | Defined | 2024-05-15 | |
| 2023-06-30 | $202,998 | 9,995 | Shares | Defined | 2023-08-14 | |
| 2022-12-31 | $554,306 | 26,804 | Shares | Defined | 2023-02-14 | |
| 2022-03-31 | $1,391,385 | 44,087 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $13,476,266 | 332,994 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $6,728,619 | 192,963 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $9,746,816 | 354,946 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $15,705,396 | 559,309 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $14,779,884 | 569,333 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $10,524,593 | 614,037 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $11,016,275 | 445,282 | Shares | Defined | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||